Organizational Factors Associated With Inappropriate Neuroleptic Drug Prescribing in Nursing Homes: A Multilevel Approach

Journal of the American Medical Directors Association

Volumn 16, Issue 7, 2015, Pages 590-597

  Laffon de Mazières, Clarisse ^a,b   Lapeyre Mestre, Maryse ^a,b   Vellas, Bruno ^a,b   de Souto Barreto, Philipe ^a,c   Rolland, Yves ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b Faculté de Médecine Centre Hospitalo universitaire   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Elderly; General practitioners; Inappropriate prescribing; Neuroleptics; Nursing homes

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DRUG INDICATION; FEMALE; GENERAL PRACTITIONER; GERIATRIC HOSPITAL; HEALTH CARE ORGANIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; NURSING HOME; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RESIDENT;

ANTIPSYCHOTIC AGENTS; HUMANS; NURSING HOMES; PSYCHOTROPIC DRUGS;

EID: 84931099479     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.01.092     Document Type: Article

References (54)

1. Larrayadieu A., Abellan van Kan G., Piau A., et al. Associated factors with antipsychotic use in assisted living facilities: A cross-sectional study of 4367 residents. Age Ageing 2011, 40:368-375.
2. Bronskill S.E., Anderson G.M., Sykora K., et al. Neuroleptic drug therapy in older adults newly admitted to nursing homes: Incidence, dose, and specialist contact. J Am Geriatr Soc 2004, 52:749-755.
3. Azermai M., Elseviers M., Petrovic M., et al. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol 2011, 26:12-20.
4. Mann E., Köpke S., Haastert B., et al. Psychotropic medication use among nursing home residents in Austria: A cross-sectional study. BMC Geriatr 2009, 9:18.
5. Rochon P.A., Stukel T.A., Bronskill S.E., et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007, 167:676-683.
6. Chen Y., Briesacher B.A., Field T.S., Tjia J., et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010, 170:89-95.
7. Schneider L.S., Dagerman K.S., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943.
8. Schneider L.S., Dagerman K., Insel P.S. Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006, 14:191-210.
9. Rochon P.A., Normand S.-L., Gomes T., et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008, 168:1090-1096.
10. Haute Autorité de Santé. Recommandations de bonne pratique. Maladie d'Alzheimer et maladies apparentées: Prise en charge des troubles du comportement perturbateurs. 2009.
11. Haute Autorité de Santé. Recommandations de bonne pratique. Confusion aiguë chez la personne âgée: Prise en charge initiale de l'agitation. 2009.
12. Journal Officiel de la République Française - arrêté du 26 avril 1999. Available at:. Accessed December 15, 2013. http://www.ehpad.org/arrete260499.pdf/view.
13. Katz P.R., Karuza J., Lima J., Intrator O. Nursing home medical staff organization: Correlates with quality indicators. J Am Med Dir Assoc 2011, 12:655-659.
14. Kuo Y.-F., Raji M.A., Goodwin J.S. Association between proportion of provider clinical effort in nursing homes and potentially avoidable hospitalizations and medical costs of nursing home residents. J Am Geriatr Soc 2013, 61:1750-1757.
15. Young Y., Inamdar S., Dichter B.S., et al. Clinical and nonclinical factors associated with potentially preventable hospitalizations among nursing home residents in New York State. J Am Med Dir Assoc 2011, 12:364-371.
16. De Souto Barreto P., Lapeyre-Mestre M., Mathieu C., et al. A multicentric individually-tailored controlled trial of education and professional support to nursing home staff: Research protocol and baseline data of the IQUARE study. J Nutr Health Aging 2013, 17:173-178.
17. Laroche M.-L., Charmes J.-P., Merle L. Potentially inappropriate medications in the elderly: A French consensus panel list. Eur J Clin Pharmacol 2007, 63:725-731.
18. Agence Régionale de Santé. Fonction des bassins de santé. Available at:. Accessed October 23, 2013. http://www.ars.midipyrenees.sante.fr/Fonction-des-bassins-de-sante.111283.0.html.
19. La filière gériatrique sanitaire en Midi-Pyrénées. Available at:. Accessed November 25, 2013. https://www.telesante-midipyrenees.fr/portail/documents/gallery_files/site/404/1195/1201.pdf.
20. Lerner N.B., Johantgen M., Trinkoff A.M., et al. Are nursing home survey deficiencies higher in facilities with greater staff turnover. J Am Med Dir Assoc 2014, 15:102-107.
21. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
22. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. J Am Med Assoc 1963, 185:914-919.
23. Cummings J.L., Mega M., Gray K., et al. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
24. Cohen-Mansfield J. Measurement of inappropriate behavior associated with dementia. J Gerontol Nurs 1999, 25:42-51.
25. Yesavage J.A., Brink T.L., Rose T.L., et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982, 17:37-49.
26. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
27. Alexopoulos G.S., Abrams R.C., Young R.C., Shamoian C.A. Cornell Scale for Depression in Dementia. Biol Psychiatry 1988, 23:271-284.
28. Diez-Roux A.V. Bringing context back into epidemiology: Variables and fallacies in multilevel analysis. Am J Public Health 1998, 88:216-222.
29. Bliese P.D., Jex S.M. Incorporating a multilevel perspective into occupational stress research: Theoretical, methodological, and practical implications. J Occup Health Psychol 2002, 7:265-276.
30. Maas C., Hox J. Sufficient sample sizes for multilevel modeling. Methodology 2005, 1:86-92.
31. Julian M. The consequences of ignoring multilevel data structures in nonhierarchical covariance modeling. Struct Equ Model 2001, 8:325-352.
32. Steenberger M., Jones B. Modeling multilevel data structures. Am J Polit Sci 2002, 46:218-237.
33. Söderfeldt B., Söderfeldt M., Jones K., et al. Does organization matter? A multilevel analysis of the demand-control model applied to human services. Soc Sci Med 1997, 44:527-534.
34. Hughes C.M., Lapane K.L., Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care 2000, 38:1164-1173.
35. Haute Autorité de Santé. Politique de l'évaluation des pratiques de l'HAS. Available at:. Accessed February 6, 2014. http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/2.1_ehpad_-_aide_memoire_ami_alzheimer.pdf.
36. Oborne C.A., Hooper R., Li K.C., et al. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002, 31:435-439.
37. Gustafsson M., Karlsson S., Lövheim H. Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacol Toxicol 2013, 14:10.
38. Stevenson D.G., Decker S.L., Dwyer L.L., et al. Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 2010, 18:1078-1092.
39. Agence nationale de sécurité du médicament et des produits de santé. Résumé des Caractéristiques du Produit - Risperdal. Available at:. Accessed February 8, 2014. http://agence-prd.ansm.sante.fr/php/ecodex/rcp/R0230567.htm.
40. Gruneir A., Lapane K.L., Miller S.C., Mor V. Does the presence of a dementia special care unit improve nursing home quality?. J Aging Health 2008, 20:837-854.
41. Bostick J.E., Rantz M.J., Flesner M.K., Riggs C.J. Systematic review of studies of staffing and quality in nursing homes. J Am Med Dir Assoc 2006, 7:366-376.
42. Schnelle J.F., Simmons S.F., Harrington C., et al. Relationship of nursing home staffing to quality of care. Health Serv Res 2004, 39:225-250.
43. Rantz M.J., Hicks L., Grando V., et al. Nursing home quality, cost, staffing, and staff mix. The Gerontologist 2004, 44:24-38.
44. Anderson R.A., Issel L.M., McDaniel R.R. Nursing homes as complex adaptive systems: Relationship between management practice and resident outcomes. Nurs Res 2003, 52:12-21.
45. Katz P.R., Karuza J., Intrator O., Mor V. Nursing home physician specialists: A response to the workforce crisis in long-term care. Ann Intern Med 2009, 150:411-413.
46. Kamble P., Chen H., Sherer J., Aparasu R.R. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 2008, 6:187-197.
47. Lang P.O., Vogt-Ferrier N., Hasso Y., et al. Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: Interventional study in 150 acutely Ill elderly patients with mental and somatic comorbid conditions. J Am Med Dir Assoc 2012, 13:406.e1-406.e7.
48. Schulze J., Glaeske G., van den Bussche H., et al. Prescribing of antipsychotic drugs in patients with dementia: A comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf 2013, 22:1308-1316.
49. National Collaborating Centre for Mental Health; Social Care Institute for Excellence. NICE-SCIE supporting caregivers and patients, 2011. Available at:. Accessed Ja-nuary 24, 2014. http://www.nice.org.uk/nicemedia/live/10998/30320/30320.pdf.
50. California Department of Public Health. California workgroup on guidelines for Alzheimer's disease management-final report, April 2008. Available at:. Accessed January 24, 2014. http://www.cdph.ca.gov/programs/alzheimers/Documents/professional_GuidelineFullReport.pdf.
51. Salzman C., Jeste D.V., Meyer R.E., et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 2008, 69:889-898.
52. Lyketsos C.G., Colenda C.C., Beck C., et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006, 14:561-572.
53. Rabins P.V., Blacker D., Rovner B.W., et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry 2007, 164:5-56. APA Work Group on Alzheimer's Disease and other Dementias.
54. Gallini A., Andrieu S., Donohue J.M., et al. Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings. Eur Neuropsychopharmacol 2014, 24:95-104.